Position in JAZZ
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$26,992,013
+$9,670,118 QoQ
Shares Held
112,014
+22.3% QoQ
Ownership
0.173%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#77
of 640 holders
Holding Since
Jun 2020
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JAZZ Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Gotham Asset Management, LLC holds $433,918,027 across 48 Biotechnology names. JAZZ ranks #6 (6.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
719,545 | $81,567,621 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
105,165 | $65,574,584 | |
| 3 | HALO |
Halozyme Therapeutics, Inc.
|
739,273 | $57,862,897 | |
| 4 | EXEL |
Exelixis, Inc.
|
892,663 | $48,569,793 | |
| 5 | ROIV |
Roivant Sciences Ltd.
|
1,349,465 | $47,757,566 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
This page
|
112,014 | $26,992,013 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
120,702 | $22,605,070 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
42,051 | $12,658,612 |
All Filings in JAZZ
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $26,992,013 | 112,014 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $17,321,895 | 91,626 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $10,404,000 | 61,200 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $6,747,105 | 51,192 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $7,266,248 | 68,472 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $6,256,539 | 50,395 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,858,456 | 15,091 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $2,343,286 | 21,033 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $640,380 | 6,000 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $344,401 | 2,860 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $470,229 | 3,823 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $3,102,935 | 23,972 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $3,618,932 | 29,192 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $4,014,709 | 27,436 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $3,814,518 | 23,944 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,592,282 | 11,946 | Shares | Sole | 2022-11-14 | |
| 2021-06-30 | $286,710 | 1,614 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $1,966,522 | 11,964 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $297,255 | 1,801 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $291,168 | 2,042 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $2,379,261 | 21,563 | Shares | Sole | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||